CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hunan Fangsheng Pharmaceutical Co Ltd Company Snapshot
Hunan Fangsheng Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hunan Fangsheng Pharmaceutical Co Ltd with three other companies in this sector in China: Shanghai Fudan Forward S&T Co Ltd (2017 sales of 735.73 million Chinese Renmimbi [US$107.30 million] of which 64% was Industrial), Zhejiang Starry Pharmaceutical Co Ltd (710.94 million Chinese Renmimbi [US$103.68 million] of which 84% was Contrast Agent), and Shandong Wohua Pharmaceutical Co., Ltd. (726.65 million Chinese Renmimbi [US$105.97 million] of which 100% was Medical Industry).

Sales Analysis. Hunan Fangsheng Pharmaceutical Co Ltd reported sales of 720.77 million Chinese Renmimbi (US$105.12 million) for the year ending December of 2017. This represents an increase of 34.9% versus 2016, when the company's sales were 534.20 million Chinese Renmimbi. Sales at Hunan Fangsheng Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2012, sales have increased a total of 117%). Sales of Pharmaceutical Manufacturing saw an increase of 44.0% in 2017, from 440.74 million Chinese Renmimbi to 634.48 million Chinese Renmimbi. Not all segments of Hunan Fangsheng Pharmaceutical Co Ltd experienced an increase in sales in 2017: sales of Pharmaceutiical Wholesale fell 9.0% to 82.93 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hunan Fangsheng Pharmaceutical Co Ltd
  Stock Performance Chart for Hunan Fangsheng Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 5.27
(Figures in Chinese Renmimbi)
1 Week 1.7%   13 Weeks 0.8%  
4 Weeks -14.4%   52 Weeks -55.2%  
 
Hunan Fangsheng Pharmaceutical Co Ltd Key Data:
  Ticker: 603998 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 720,769,349
(Year Ending Jan 2018).
Employees: 1,084
  Currency: Chinese Renmimbi Market Cap: 2,205,128,577
  Fiscal Yr Ends: December Shares Outstanding: 418,430,470
  Share Type: A Gu Closely Held Shares: 221,368,275
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.